Community Member
16 days agoI have EGFR-positive lung cancer and am currently taking Tagrisso (osimertinib). I came across an article about promising results for lorlatinib in ALK-positive lung cancer, but I learned this treatment is for a different genetic mutation than mine. It made me realize how important it is to focus on research and treatments specific to EGFR-positive lung cancer like what I have. I'd love to connect with others who have EGFR-positive lung cancer to hear about your experiences. • What has your journey with EGFR-positive lung cancer been like? • Are there any tips or resources that have been helpful for you along the way? Link: https://www.lungcancerresearchfoundation.org/crown-trial-7-year-update/

Lung Cancer Research Foundation
CROWN Trial: 7-year update - Lung Cancer Research Foundation
The good newsThe 7-year outcomes of the CROWN Trial were presented at the annual American Society of Clinical Oncology (ASCO) meeting. Why it’s importantLorlatinib is a third generation ALK-tyrosine kinase […]
Community Member
16 days agoConnecting with others who share the same genetic mutation can provide valuable insights and emotional support during treatment. This community has many members navigating EGFR-positive lung cancer who understand the unique aspects of targeted therapy and can share their experiences with treatments, side effects, and daily management strategies. Consider engaging with responses to learn from others' journeys and find the peer support that can make such a meaningful difference.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.